Member Contact: Silvio Tiziani
Position: Chief Operating Officer
Industry: Academic Research Organisation
The Australian Regenerative Medicine Institute (ARMI) is a state-of-the-art research facility that opened in April 2009. It was established with support from Monash University, the Government of Victoria and the Australian Government.
ARMI focuses on understanding basic mechanisms that underlie regeneration. This research aims to prevent, halt and reverse damage to vital organs due to disease, injury or genetic conditions. Ultimately, the aim is treatments for conditions such as neurodegenerative disorders, diabetes, arthritis, musculo-skeletal and cardiovascular diseases.
Research at ARMI is structured along four integrated Discovery Pipelines aimed at driving discoveries from the lab bench to the patient.
The pipelines exploit the evolutionary and developmental diversity of research platforms and systems biological approaches within the Institute to explore specific aspects of the regenerative process. These will include disease targets such as heart, muscle and nervous systems, to more general features of regeneration such as stem cells and the immune system.
Each pipeline engages established leaders of international standing who support young groups at a creative stage of their careers.
DISCOVERY PIPELINE 1: Heart and muscle development and regeneration
DISCOVERY PIPELINE 2: Immunity and Regeneration
DISCOVERY PIPELINE 3: Stem cells and Regeneration
DISCOVERY PIPELINE 4: Neural regeneration